» Articles » PMID: 29729305

Environmental Factors and Eosinophilic Esophagitis

Overview
Date 2018 May 6
PMID 29729305
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence and prevalence of eosinophilic esophagitis (EoE) have markedly increased over the past 2 decades, outpacing increased detection of the disease. Although genetic susceptibility markers for EoE have begun to be elucidated, the rate at which EoE has increased in incidence suggests environmental factors predominate. Despite many advances in understanding of the pathogenesis of EoE, the cause of EoE is unknown. This article reviews the emerging data related to environmental risk factors for EoE. Many of these environmental factors are rooted in the theoretical framework of the hygiene hypothesis, specifically mediation of disease development through dysbiosis. Other hypotheses are based on associations that have been observed in studies of non-EoE allergic disease. We describe the evidence that early-life exposures, including antibiotic use, acid suppression, and cesarean delivery, can increase the risk of disease. We also describe the evidence that infectious agents, such as Helicobacter pylori, are inversely associated with disease. Current evidence on geographic risk factors, such as population density, climate zone, and seasonality, is reviewed. We also describe behavioral factors that have been evaluated. Limitations of the existing research are discussed, and recommendations for future areas of research, including assessment of gene-environment interaction, are presented.

Citing Articles

[Eosinophilic esophagitis].

Greuter T Inn Med (Heidelb). 2025; 66(2):156-164.

PMID: 39792264 DOI: 10.1007/s00108-024-01828-7.


Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses.

Matsuyama K, Yamada S, Sato H, Zhan J, Shoda T J Gastroenterol. 2024; 59(11):963-978.

PMID: 39297956 PMC: 11496339. DOI: 10.1007/s00535-024-02151-6.


Perinatal Environmental Risks for Eosinophilic Esophagitis: A Systemic Review and Meta-Analysis.

Wongjarupong N, Delbrune M, Songtanin B, Reardon E, Moutsoglou D, Christian V Cureus. 2024; 16(8):e66326.

PMID: 39246975 PMC: 11377357. DOI: 10.7759/cureus.66326.


Amniotic fluid modifies esophageal epithelium differentiation and inflammatory responses.

Rochman M, Klinger A, Caldwell J, Sadovsky Y, Rothenberg M Am J Physiol Gastrointest Liver Physiol. 2024; 327(5):G629-G639.

PMID: 39189791 PMC: 11559652. DOI: 10.1152/ajpgi.00197.2024.


Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?.

Melhem H, Hendrik Niess J Int J Mol Sci. 2024; 25(15).

PMID: 39126102 PMC: 11313654. DOI: 10.3390/ijms25158534.


References
1.
Dominguez-Bello M, Costello E, Contreras M, Magris M, Hidalgo G, Fierer N . Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010; 107(26):11971-5. PMC: 2900693. DOI: 10.1073/pnas.1002601107. View

2.
Wickens K, Black P, Stanley T, Mitchell E, Fitzharris P, Tannock G . A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008; 122(4):788-794. DOI: 10.1016/j.jaci.2008.07.011. View

3.
Dellon E, Shaheen O, Koutlas N, Chang A, Martin L, Rothenberg M . Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthood. Dis Esophagus. 2020; 34(2). PMC: 7874052. DOI: 10.1093/dote/doaa074. View

4.
Liacouras C . Clinical presentation and treatment of pediatric patients with eosinophilic esophagitis. Gastroenterol Hepatol (N Y). 2011; 7(4):264-7. PMC: 3127030. View

5.
Azad M, Konya T, Maughan H, Guttman D, Field C, Chari R . Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013; 185(5):385-94. PMC: 3602254. DOI: 10.1503/cmaj.121189. View